Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Gynecological Cancers -

Gynecological Cancers

Genetic and Epigenetic Targets and Drug Development
Buch | Softcover
XII, 173 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2016
Springer International Publishing (Verlag)
978-3-319-81395-0 (ISBN)
CHF 194,70 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers. 
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development  also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today's practicing oncologist.

Antonio Giordano, MD, PhDProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USA Marcella Macaluso, PhDAssociate ProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USA

I. Epigenetic Mechanisms in Gynecological Cancers.- 1.Epigenetic Mechanisms in Gynecological Cancer.- 2.Pharmacoepigenomics and Pharmacovigilance in Gynecological Cancers.- II. Current Standard of Care for the Treatment of Gynecological Tumors.- 3.Advances in Cervical Cancer and Ongoing Clinical Trials.- 4.Advances in Ovarian Cancer and Ongoing Clinical Trials.- 5.Novel Methods for Prevention and Early Diagnosis of Ovarian and Endometrial Cancers.- III. Gynecological Cancers: New Therapies, Drug Development, and Challenges.- 6.Developmental Therapeutics for Gynecologic Cancers: An Overview.- IV. Fertility Preservation in the Setting of Malignant Disease.- 7.Preservation of Fertility in Gynecological Malignancies.- V. Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment and Survival.- 8.Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment and Survival.

Erscheint lt. Verlag 31.5.2018
Reihe/Serie Current Clinical Oncology
Zusatzinfo XII, 173 p. 12 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 502 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Gynäkologie / Geburtshilfe
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte drug development • gynecologic cancers • Gynecologic tumors • gynecology • Oncology
ISBN-10 3-319-81395-1 / 3319813951
ISBN-13 978-3-319-81395-0 / 9783319813950
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Wolfgang Janni; Katharina Hancke; Tanja Fehm …

Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 139,95